SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-14-018974
Filing Date
2014-05-06
Accepted
2014-05-06 14:17:52
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 ISIS PHARMACEUTICALS INC 10-Q 3-31-2014 form10q.htm 10-Q 906709
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 26301
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8848
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8828
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7033
  Complete submission text file 0001140361-14-018974.txt   7652029

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT isis-20140331.xml EX-101.INS 1343969
7 XBRL TAXONOMY EXTENSION SCHEMA isis-20140331.xsd EX-101.SCH 51862
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE isis-20140331_cal.xml EX-101.CAL 55912
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE isis-20140331_def.xml EX-101.DEF 210036
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE isis-20140331_lab.xml EX-101.LAB 708890
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE isis-20140331_pre.xml EX-101.PRE 332509
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
ISIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19125 | Film No.: 14816490
SIC: 2834 Pharmaceutical Preparations